180 related articles for article (PubMed ID: 14533836)
1. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
Maino KL; Norwood C; Stashower ME
Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
3. [Capecitabine-induced hyperpigmentation].
Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
[TBL] [Abstract][Full Text] [Related]
4. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
5. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
6. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
7. Onycholysis associated with capecitabine in patients with breast cancer.
Hogeling M; Howard J; Kanigsberg N; Finkelstein H
J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine induced cutaneous hyperpigmentation: report of a case.
Pui JC; Meehan S; Moskovits T
J Drugs Dermatol; 2002 Sep; 1(2):202-5. PubMed ID: 12847748
[TBL] [Abstract][Full Text] [Related]
9. [Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].
Tejera A; Bosch RJ; López N; Herrera E
Actas Dermosifiliogr; 2006 Oct; 97(8):536-8. PubMed ID: 17067535
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
11. Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.
Scheithauer W; Blum J
Oncology (Williston Park); 2004 Aug; 18(9):1161-8, 1173; discussion 1173-6, 1181-4. PubMed ID: 15471200
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine and PPE syndrome: a case report.
LoRusso PM
Breast J; 2003; 9(1):64-5. PubMed ID: 12558679
[No Abstract] [Full Text] [Related]
13. [Breast cancer and the hand-foot syndrome].
Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
[TBL] [Abstract][Full Text] [Related]
14. [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer].
Sauter C; Saborowski A; Ockenfels HM
Hautarzt; 2007 Jul; 58(7):619-22. PubMed ID: 17066280
[TBL] [Abstract][Full Text] [Related]
15. Hand and foot syndrome secondary to capecitabine.
Lal HS
Indian J Dermatol Venereol Leprol; 2014; 80(5):427-30. PubMed ID: 25201844
[TBL] [Abstract][Full Text] [Related]
16. Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.
Yoshimoto N; Yamashita T; Fujita T; Hayashi H; Tsunoda N; Kimura M; Tsuzuki N; Yamashita H; Toyama T; Kondo N; Iwata H
Breast Cancer; 2010 Oct; 17(4):298-302. PubMed ID: 19789949
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Caronia D; Martin M; Sastre J; de la Torre J; García-Sáenz JA; Alonso MR; Moreno LT; Pita G; Díaz-Rubio E; Benítez J; González-Neira A
Clin Cancer Res; 2011 Apr; 17(7):2006-13. PubMed ID: 21325291
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine induced inflammation of actinic keratoses.
Krathen M; Treat J; James WD
Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
[TBL] [Abstract][Full Text] [Related]
20. Nail and periungual toxicity following capecitabine therapy.
Vaccaro M; Barbuzza O; Guarneri F; Guarneri B
Br J Clin Pharmacol; 2008 Aug; 66(2):325-6. PubMed ID: 18384441
[No Abstract] [Full Text] [Related]
[Next] [New Search]